Stem cell researchers: Better cytomegalovirus drugs are needed

09/22/2013 | Healio

Drug resistance was seen in almost 15% of hematopoietic stem cell transplant patients who received pre-emptive cytomegalovirus therapy in a study at Hadassah Hebrew University Medical Center in Israel. The study shows the need for cytomegalovirus drugs that act on different targets and can be better tolerated by patients, researchers wrote in The Journal of Infectious Diseases.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR